710 Development of IL-33 as a novel immunotherapy of cancer

Bibliographic Details
Main Authors: Binfeng Lu, Joshua Zhong, Runzi Sun
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-250798c2e03d40f5b7a119386852a706
record_format Article
spelling doaj-250798c2e03d40f5b7a119386852a7062020-12-11T10:03:33ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0710710 Development of IL-33 as a novel immunotherapy of cancerBinfeng Lu0Joshua Zhong1Runzi Sun2Aff1 0000 0004 0456 9819grid.478063.eUPMC Hillman Cancer Center Pittsburgh PA USA 1Carlmont High School, Belmont, CA, USA2University of Pittsburgh, Pittsburgh, PA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Binfeng Lu
Joshua Zhong
Runzi Sun
spellingShingle Binfeng Lu
Joshua Zhong
Runzi Sun
710 Development of IL-33 as a novel immunotherapy of cancer
Journal for ImmunoTherapy of Cancer
author_facet Binfeng Lu
Joshua Zhong
Runzi Sun
author_sort Binfeng Lu
title 710 Development of IL-33 as a novel immunotherapy of cancer
title_short 710 Development of IL-33 as a novel immunotherapy of cancer
title_full 710 Development of IL-33 as a novel immunotherapy of cancer
title_fullStr 710 Development of IL-33 as a novel immunotherapy of cancer
title_full_unstemmed 710 Development of IL-33 as a novel immunotherapy of cancer
title_sort 710 development of il-33 as a novel immunotherapy of cancer
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT binfenglu 710developmentofil33asanovelimmunotherapyofcancer
AT joshuazhong 710developmentofil33asanovelimmunotherapyofcancer
AT runzisun 710developmentofil33asanovelimmunotherapyofcancer
_version_ 1724386539740332032